Sunshin Kim

Targeted Therapy Branch, Goyang 10408
Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition.

Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: January 22, 2025

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Journal: MedComm

Published: December 30, 2024

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones.

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones.

Journal: Experimental & molecular medicine

Published: November 13, 2024

ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer.

ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 02, 2024

Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy.

Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy.

Journal: Cancers

Published: December 27, 2023

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance.

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance.

Journal: Cancers

Published: June 06, 2023

Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.

Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.

Journal: Cancer research

Published: May 26, 2023

Splicing signature database development to delineate cancer pathways using literature mining and transcriptome machine learning.

Splicing signature database development to delineate cancer pathways using literature mining and transcriptome machine learning.

Journal: Computational and structural biotechnology journal

Published: January 11, 2023

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation.

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation.

Journal: Biomolecules & therapeutics

Published: January 07, 2023

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 21, 2022

Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer.

Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer.

Journal: British journal of cancer

Published: October 17, 2022

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2.

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2.

Journal: Frontiers in molecular biosciences

Published: June 08, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026